Trial Profile
A Study to Investigate the Effect of Six-month Treatment with Novel Oral Anticoagulants on Cerebral Blood Flow Using Brain Perfusion SPECT
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2018
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary)
- Indications Embolism; Stroke; Thromboembolism; Thrombosis
- Focus Pharmacodynamics
- 19 Sep 2018 New trial record
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology.